Genetically Modified Cells TRIZ Cases

Chemical derivers of totipotency induce stable totipotent stem cells in vitro.

Episomal vectors deliver CEBPA, CEBPB, FOXA1, and FOXA3 to induce hepatocyte lineage cells without genomic integration.

Segmented reprogramming converts non-limb fibroblasts into authentic limb progenitors with reliable patterning capabilities.

Hypotonic lysis of feeder cells extracts nucleic acids and toxic cytoplasm to maintain antigen-presenting functions without crosslinking risks.

Culturing somatic cells under hypoxic conditions during nuclear reprogramming to establish induced pluripotent stem cells.

Differentiating induced pluripotent stem cells into haemogenic progenitor cells without intermediate purification or serum.

A transient transfection process using polyethylenimine reagents with 293E cells expressing Epstein-Barr virus nuclear antigen 1.

CpG oligodeoxyribonucleotides restore viability and cytotoxicity after cryopreservation.

MORT RNA reverses cell immortality without genomic alterations, resolving detection complexity via methylation status.

Myosin inhibitors replace macromolecular substances to improve transdifferentiation efficiency.

Transfecting adenoviruses into adipose-derived stem cells enables stable hFIX secretion, reducing immune response risks in hemophilia B treatment.

Zinc finger nucleases integrate XIST into DYRK1A loci to silence Chr 21, correcting genetic imbalance in trisomy models.

Engineered yeast cells synthesize complex glycosylated products using UDP-GlcNAc precursors.

Defined culture media support immortalized bovine cell growth, eliminating expensive proprietary serum requirements and reducing production costs.

Regenerative fibroblasts treat ovarian failure by secreting growth factors that stimulate oocyte production and suppress inflammation.

CRISPR editing removes HLA antigens from stem cell derived platelets to eliminate cross-reactivity during antibody detection.

Co-expressing MDM2 D300A and E1B19K genes in CHO cells inhibits apoptosis, extending culture longevity and increasing protein titers five-fold.

A serum-free protocol differentiates human pluripotent stem cells into alveolar-like macrophages using defined growth factors.

Segmenting iPSC generation from re-differentiation yields rejuvenated BCMA-specific CD8+ T cells with sustained cytotoxicity against multiple myeloma.

Novel human erythroid progenitor cell lines resolve low infectivity detection sensitivity by enabling reliable B19 particle quantification.

lncRNA CIR6 drives mesenchymal stem cell differentiation into cardiomyocytes, resolving unregulated tissue regeneration in myocardial infarction therapy.

Removing the Keap1 gene from natural killer cells prevents oxidative stress suppression, thereby maintaining high anticancer function.

TGFbeta receptor inhibitors block signaling pathways to increase induced pluripotent stem cell production efficiency and reduce induction time.

Regulating ornithine metabolism in host cells to modulate high mannose glycoform content of recombinant proteins.

Fusing ventral and dorsal forebrain organoids creates a bi-differentiated neuronal tissue model.

CPV-VHH-E3 nanobody binds canine parvovirus antigens to resolve biosafety risks from live attenuated vaccines.

Computational simulation evolves multicellular organism structures to resolve the contradiction between manufacturing precision and physiological robustness.

Measuring transgenic animal cell diameter predicts gene transfer efficiency, replacing time-consuming flow cytometry with rapid image analysis.

Segmenting antibody targeting from NK cells overcomes antigen shedding resistance while enhancing cytotoxicity efficacy.

A T cell progenitor uses a Notch pathway-induced promoter to control transgene expression during maturation.

Episomal vectors carrying nuclear reprogramming factors and EBNA-1 drive somatic cell conversion to induced pluripotent stem cells.